This Is Not Investment Advice
The Market Right Now - Medical Biomed/Biotech
The Industry Group Medical - Biomed/Biotech has been on the move in recent months and we already hold one Long position there. Should we add another Long?
Let’s check in on our current Long and the group in general and see what is going on here.
Will Your Retirement Income Last?
A successful retirement can depend on having a clear plan. Fisher Investments’ The Definitive Guide to Retirement Income can help you calculate your future costs and structure your portfolio to meet your needs. Get the insights you need to help build a durable income strategy for the long term.
GLUE
GLUE Weekly
BIOA
BIOA Weekly
Thoughts and observations:
Holding GLUE . . . . added to it very slightly few weeks back . . . . MGDs or Molecular Glue Degraders . . . . a platform for innovation to go after previously untouchable proteins . . . . open ended . . . we like this . . . . holding . . . .
Current administration sending signals . . . . obviously it has lit a fire under this Industry Group . . . . open mind . . . . there likely are far superior ways of doing business in Biomed/Biotech . . . . wind in their sails from a macro standpoint . . . .
BIOA have no position currently . . . . very interested . . . . teamed up with Lilly and Novartis on platform targeting novel approaches to aging and metabolism . . . . couple of major news announcements very recently on expansion of pipeline potential . . . . market received it very well . . . . just did an offering . . . . liquidity improved meaningfully . . . .
BIOA . . . . market crushed it Dec 2024 when they had to discontinue one path . . . . market looked past that and has placed it in a bullish pattern for multiple months now . . . . stock is showing good respect for 10 Week EMA . . . . strong bounces off of it on high Volume . . . . Up/Down Volume is currently quite strong . . . . . obviously RS off the charts and Industry Group RS is rated A+ currently . . . . I’m interested at a desirable entry point . . . .
75% of stocks follow the overall market trend . . . . .
